A retrospective to assess whether the combination use of ICI and lenvatinib provides better survival than lenvatinib alone in advanced stage HCC patients
Latest Information Update: 25 Apr 2022
At a glance
- Drugs Lenvatinib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 29 Jan 2021 New trial record